Methods and compositions for the manufacture of C-3′ and C-4′ anthracycline antibiotics
AssigneeHouston Pharmaceuticals, Inc.
InventorsWaldemar Priebe, Izabella Fokt, Teresa Przewloka, Marta Krawczyk, Piotr Skibicki, Grzegorz Grynkiewicz, Roman Perez-Soler
Life of this patent
Estimating the term…
Abstract
The present invention discloses new and novel substituted anthracyclines with modified alkyl-aromatic ring substitutions on the C-3′ of the sugar moiety or modified or unmodified alkyl-aromatic ring substitutions at the C-4′ of the sugar moiety. It also discloses novel methods for the preparation of sugar substrates and methods for the preparation of anthracycline antibiotics. These anthracycline analogs show high cytotoxicity in vitro against several tumor cell lines.
Claims48
A substituted anthracycline having the formula:
- wherein, R1 denotes an alkyl chain, a (—COCH2R13) group or a (C(OH)—CH2R13);
- wherein, R13 is a hydrogen (—H) group, a hydroxyl group (—OH);
- a methoxy group (—OCH3), an alkoxy group having 1-20 carbon atoms, an alkyl group having 1-20 carbon atoms, an aryl group having 1-20 carbon atoms, a fatty acyl group having the general structure —O—CO(CH2)nCH3, wherein n=an integer from 1 to about 20, a fatty acyl group having the general structure —O—CO(CH2)l(CH═CH)m(CH2)nCH3, wherein 1 is an integer between 1 to 3, m is an integer between 1 and 6, and n is an integer between 1 and 9, a —OCO—(CH2)n—CH2NH2, or OCO—(CH2)n—CO2H:
- each of R2 and R3 is, independently of the other, a hydrogen (—H), a hydroxyl group (—OH) or a methoxy group (—OCH3);
- R4 is a hydrogen (—H) group, a methoxy group (—OCH3), a hydroxyl group (—OH) or a halide;
- each of Y1 and Y2 is, independently of the other, a double bonded oxygen, sulphur, or nitrogen atom;
- Z is a —H, —OH, a —CO2H group or a —CO2R group;
- R7, R8, are, independently, —H, —OH, a halide, —OR19, —SH, —SR19, —NH2, —NHR19, —N(R19)2 or —CH3, and R7 can additionally be a saccharide, wherein R19 an alkyl chain, an alkylating moiety, a cycloalkyl chain, a cyclic ring, or a hydrogen;
- R9 is an —H, —CH3, alkyl, aryl, CH2OH, or a CH2F group;
- R10, R11 and R12 are, independently, —H, —OH, a halide, —OR, —SH, —SR, —NH2, —NHR, —N(R)2, or a —CH3;
- one of R5 and R6 is a —H;
- one of R5 and R6 is a X-alkyl-aromatic-ring (—XAAR) substituent, wherein, A is an alkyl group and wherein, AR is an substituted phenyl ring, or a substituted five-member ring, a heteroatomic five-member ring, or a heteroatomic six-member ring, of the form;
- wherein, R14-R18 are independently a (—H) group, a hydroxyl group (—OH), a methoxy group (—OCH3), a nitro group (—NO2), an amine group (—NH2), a halide, an alkoxy group having 1-20 carbon atoms, an alkyl group having 1-20 carbon atoms, an aryl group having 1-20 carbon atoms, an alkyl-amino group, an alkyl-thio group, a cyano group (CN, SCN), an —CO2H group or an —CO2R group;
- and
- the aromatic ring may be disubstituted, trisubstituted, tetrasubstituted or pentasubstituted;
- and
- X is a —N, a —S, a —SO, or —SO2 group;
- and
- A is (CH2)n where n=0-10;
- wherein, if R5 is a XAAR substituent R6 is not and if R6 is a XAAR substituent R5 is not.
A substituted anthracycline having the formula:
- wherein, R1 denotes an alkyl chain, a (—COCH2R13) group or a (C(OH)—CH2R13);
- wherein, R13 is a hydrogen (—H) group, a hydroxyl group (—OH);
- a methoxy group (—OCH3), an alkoxy group having 1-20 carbon atoms, an alkyl group having 1-20 carbon atoms, an aryl group having 1-20 carbon atoms, a fatty acyl group having the general structure —O—CO(CH2)nCH3, wherein n=an integer from 1 to about 20, a fatty acyl group having the general structure —O—CO(CH2)l(CH═CH)m(CH2)nCH3, wherein 1 is an integer between 1 to 3, m is an integer between 1 and 6, and n is an integer between 1 and 9, —OCO—(CH2)n—CH2NH2, or OCO—(CH2)n—CO2H;
- each of R2 and R3 is, independently of the other, a hydrogen (—H), a hydroxyl group (—OH) or a methoxy group (—OCH3);
- R4 is a hydrogen (—H) group, a methoxy group (—OCH3), a hydroxyl group (—OH) or a halide;
- each of Y1 and Y2 is, independently of the other, a double bonded oxygen, sulphur, or nitrogen atom;
- Z is a —H, —OH, a —CO2H group or a —CO2R group;
- R5, R6, are, independently, —H, —OH, a halide, —OR19, —SH, —SR19, —NH2, —NHR19, —N(R19)2 or —CH3, and R can additionally be a an alkylating moiety, wherein R19 an alkyl chain, an alkylating moiety, a cycloalkyl chain, a cyclic ring, or a hydrogen;
- R9 is an —H, —CH3, alkyl, aryl, CH2OH, or a CH2F group;
- R10, R11 and R12 are, independently, —H, —OH, a halide, —OR, —SH, —SR, —NH2, —NHR, —N(R)2, or —CH3;
- one of R7 and R8 is a —H;
- one of R7 and R8 is a X-alkyl-aromatic-ring (—XAAR) substituent, wherein, A is an alkyl group and wherein, AR is an unsubstituted phenyl ring, substituted phenyl ring, a substituted five-member ring or a heteroatomic five-member ring, of the general form;
- wherein, R14-R18 are independently a (—H) group, a hydroxyl group (—OH), a methoxy group (—OCH3), a nitro group (—NO2), an amine group (—NH2), a halide, an alkoxy group having 1-20 carbon atoms, an alkyl group having 1-20 carbon atoms, an aryl group having 1-20 carbon atoms, an alkyl-amino group, an alkyl-thio group, a cyano group (CN, SCN), an —CO2H group or an —CO2R group;
- and
- the aromatic ring may be disubstituted, trisubstituted, tetrasubstituted or pentasubstituted;
- and
- X is a —O, —N, —S, —SO or —SO2 group;
- and
- A is (CH2)n where n=0-10;
- wherein, if R7 is a XAAR substituent R8 is not and if R8 is a XAAR substituent R7 is not.
A method for the synthesis of a 4′—O—benzylated sugar comprising:
- (a) obtaining a C4 acetylated sugar;
- and
- (b) directly benzylating the acetylated sugar at C4 with a benzyl group;
- wherein the benzylation of the acetylated sugar at C4 with a benzyl group produces a 4′—O—benzylated sugar.
A method for synthesis of 4—O—alkylated glycals blocked and unblocked at C-3 comprising direct and selective alkylation by an alkylating agent of C-4 acylated glycal.
A method for the synthesis of amine containing anthracyclines comprising:
- (a) obtaining a substituted sugar azide, wherein the azido substitution is at the 1′, 2′, 3′, 4′ or 5′ position on the sugar, said azide serving as a masked and neutral form of amine substituent;
- (b) subjecting said azide to a coupling reaction with an anthracyclinone;
- and
- (c) subjecting said azide to a reduction reaction;
- wherein an amine containing anthracycline is produced.
A sugar having the structure:
A sugar having the structure:
A sugar having the structure:
A sugar having the structure:
A sugar having the structure:
A sugar having the structure:
A sugar having the structure:
A sugar having the structure:
A sugar having the structure:
A sugar having the structure:
Dependencies are inferred from the claim text.